NHS National Framework for Transition products (Axitinib and Eltrombopag)
key details
| Value | £80,909,200 (£97,090,800 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, East Midlands, West Midlands, East of England, South East, South West |
| Deadline | 4 Jul 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-050bb9 |
Awards (7)
This procurement was awarded to 7 suppliers. Values shown are per-award; the notice total is £80,909,200.
| Supplier | Value | Date | Status |
|---|---|---|---|
| DR REDDY'S LABORATORIES (UK) LIMITED shared | £52,385,000 | 15 Jul 2025 | active |
| NOVARTIS PHARMACEUTICALS UK LIMITED shared | £52,385,000 | 15 Jul 2025 | active |
| PERENNIAL PHARMA LTD shared | £52,385,000 | 15 Jul 2025 | active |
| PFIZER LIMITED shared | £52,385,000 | 15 Jul 2025 | active |
| TEVA UK LIMITED shared | £52,385,000 | 15 Jul 2025 | active |
| THORNTON & ROSS LIMITED shared | £52,385,000 | 15 Jul 2025 | active |
| WOCKHARDT UK LIMITED shared | £52,385,000 | 15 Jul 2025 | active |
description
Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025
Offer reference number: CM/TNS/25/5722
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/25/5722/01 Axitinib and Eltrombopag
Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months)
Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months)
Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months)
Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.
documents
- https://www.find-tender.service.gov.uk/Notice/029971-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-1893 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 1 May 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 018549-2025 |
| 4 Jun 2025 | Tender notice (UK4) | Procurement Act 2023 | 029971-2025 |
| 30 Jul 2025 | Contract award (UK6) | Procurement Act 2023 | 044175-2025 |
| 4 Sept 2025 | Contract details (UK7) | Procurement Act 2023 | 054095-2025 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.